Latest Biogen Idec Stories
- Experienced leader and expert clinician to deliver strong outcomes for patients in the areas of Neurology and Immunology ROCKLAND, Mass., April 1, 2015 /PRNewswire/ -- EMD
Proven Business Leader to Oversee Commercialization of Octreotide Capsules NEWTON, Mass. and JERUSALEM, March 16, 2015 /PRNewswire/ -- Chiasma, Inc., a U.S.
If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization
CARLSBAD, Calif., March 6, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
PHILADELPHIA, March 2, 2015 /PRNewswire-USNewswire/ -- Phillip Sharp, Institute Professor at the Massachusetts Institute of Technology and a faculty member of the Department of Biology and the
Fifteen Accepted Abstracts Include New Data From: NORTH CHICAGO, Ill., Feb.
CRANFIELD, England, February 26, 2015 /PRNewswire/ -- Now in its fifth year, the Productive Innovation Index (PII) celebrates the top 30 pharmaceutical companies most successful
WASHINGTON, Feb. 24, 2015 /PRNewswire-USNewswire/ -- Over 200 patient advocates are in Washington D.C.
- A bereavement by loss of parents or children; the state of being orbate; orbation.